White Blood Cell Count Measured Prior to Cancer Development Is Associated with Future Risk of Venous Thromboembolism – The Tromsø Study

• Kristine Blix,

  Affiliation Hematological Research Group, Department of Clinical Medicine, University of Tromsø and Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway

  ⨯
• Hilde Jensvoll ,

  * E-mail: hilde.jensvoll@uit.no

  Affiliation Hematological Research Group, Department of Clinical Medicine, University of Tromsø and Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway

  ⨯
• Sigrid K. Brækkan,

  Affiliation Hematological Research Group, Department of Clinical Medicine, University of Tromsø and Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway

  ⨯
• John-Bjarne Hansen

  Affiliation Hematological Research Group, Department of Clinical Medicine, University of Tromsø and Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway

  ⨯